Written Evidence: NHS Science and Technology Committee's Inquiry on Genomics and Genome Editing
By Center for Genetics and Society,
National Health Service
| 10. 24. 2017
- Thank you for the opportunity to contribute evidence toward your investigation of genomics and genome editing in the NHS.
- The Center for Genetics and Society is a public-interest non-governmental organization working to encourage responsible uses and effective societal governance of human genetic and reproductive technologies and other emerging technologies. We work with a vibrant international network of scientists, health professionals, civil society leaders, and others. The Center supports benign and beneficent medical applications of these technologies, and opposes those applications that objectify and commodify human life and threaten to divide human society.
- In response to The Committee’s invitation for written evidence on the recommendations made by the Chief Medical Officer in ‘Generation Genome,’ and in keeping with our organizational mission, our comments focus on the importance of maintaining the existing prohibition on germline genome editing for reproduction or clinical applications, even as the NHS moves to integrate genomic medicine and somatic gene therapies. We also address some of the future lines of inquiry included in the previous committee’s report.
- Here we summarize the points that follow:
- The UK should maintain a ban on human germline editing for reproduction...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...
By Nahlah Ayed, CBC Listen | 10.22.2025
Egg freezing is one of today’s fastest-growing reproductive technologies. It's seen as a kind of 'fertility insurance' for the future, but that doesn’t address today’s deeper feelings of uncertainty around parenthood, heterosexual relationships, and the reproductive path forward. In this...
